EP Patent

EP0765865A1 — 2-acylaminopropanol compound and medicinal composition

Assigned to Seikagaku Corp · Expires 1997-04-02 · 29y expired

What this patent protects

This invention relates to a 2-acylaminopropanol compound represented by the formula (I): (wherein R 1 represents a phenyl group which may be substituted by 1 to 3 same or different substituents selected from alkyl, alkoxy, hydroxyl, hydroxyalkyl and nitro, R 2 represents …

USPTO Abstract

This invention relates to a 2-acylaminopropanol compound represented by the formula (I): (wherein R 1 represents a phenyl group which may be substituted by 1 to 3 same or different substituents selected from alkyl, alkoxy, hydroxyl, hydroxyalkyl and nitro, R 2 represents the following formula (II), (III), (IV), (V) or (VI), (wherein R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , m and p are those defined in the specification) R 11 represents a hydrogen atom or a hydroxyl group, and n represents an integer of 3 to 15) or a pharmaceutically acceptable salt thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP0765865A1
Jurisdiction
EP
Classification
Expires
1997-04-02
Drug substance claim
No
Drug product claim
No
Assignee
Seikagaku Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.